For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Its active ingredient, semaglutide, is a synthetic version of the natural hormone GLP-1. This hormone plays a vital role in regulating blood sugar levels. When administered once per week ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

The researchers found that low-dose semaglutide (0.25 mg/week for four weeks, 0.5 mg/week for four weeks, and 1 mg for one week ... with medium to large effect sizes for alcohol consumed (grams) and ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

After one year, the tirzepatide group experienced an average weight loss of 21.4% and a 0.67 percentage point reduction in HbA1c, while the semaglutide group saw an average 9.1% weight loss and ...